A Randomized, Double-blind, Placebo-controlled Trial of Golimumab+Methotrexate Versus Methotrexate Alone in Methotrexate-naive Patients With Psoriatic Arthritis
Phase of Trial: Phase III
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Golimumab (Primary) ; Folic acid; Methotrexate
- Indications Psoriatic arthritis
- Focus Adverse reactions; Therapeutic Use
- 29 Jun 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2012-005214-19).
- 25 Jun 2013 New trial record
- 20 Jun 2013 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.